Rankings
▼
Calendar
PRGO Q2 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena
PRGO
Perrigo Company plc
$1B
Q2 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
-0.9% YoY
Gross Profit
$363M
34.4% margin
Operating Income
$45M
4.3% margin
Net Income
-$8M
-0.8% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
$76M
Free Cash Flow
$57M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$10.1B
Total Liabilities
$5.6B
Stockholders' Equity
$4.5B
Cash & Equivalents
$454M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.1B
-0.9%
Gross Profit
$363M
$395M
-8.1%
Operating Income
$45M
-$27M
+271.3%
Net Income
-$8M
-$108M
+92.3%
Revenue Segments
Consumer Self-Care Americas
$622M
59%
Consumer Self-Care International
$434M
41%
Geographic Segments
UNITED STATES
$611M
57%
Europe
$422M
40%
Other Geographical Areas
$24M
2%
IRELAND
$10M
1%
← FY 2025
All Quarters
Q3 2025 →